Artificial intelligence (AI) is certainly making its way into medicine. This tool is very promising for the Dr Collins Oghor, co-founder and CEO of Collogh Cares, a Montreal start-up that works to prevent and treat kidney failure. The role that AI will play there could not only improve the quality of life of millions of people, but also open up new avenues in health care and research.
Collins Oghor co-founded Collogh Cares just two years ago to provide more support for people with kidney disease. “In the United States, where 37 million people suffer from chronic kidney disease [IRC], patients are seen every three months and their contact with a doctor lasts an average of seven minutes. This is unacceptable”, explains the scientist.
This lack of support means that patients go home without really knowing how to manage their state of health, says the doctor-entrepreneur. “What do they need to change in their diet and how do you know quickly if it’s beneficial?” If they take eight different drugs, what if there are side effects? The patient is left to himself. »
The start-up, which receives the support of Next AI and which has taken up residence in the offices of this incubator associated with the School of Leaders of HEC Montreal, therefore offers patients a panoply of tools (measurement of blood pressure, blood sugar level, sleep time, reminder to take medication, etc.) to monitor the progress of the disease. This initiative alone will make a big difference in the quality of life of its users, says the businessman.
When artificial intelligence is added to it, what was once seen as science fiction could become reality, illustrates the Dr Oghor. But for now, Collogh Cares is relying above all on an application that takes the form of a ” coach digital health”.
In addition to storing data, this app gives patients the opportunity to improve their knowledge of kidney disease and thus develop better reflexes. A quiz even allows you to test the user’s knowledge.
As for artificial intelligence, it undoubtedly represents one of the greatest challenges for the young Montreal SME, recognizes its co-founder. Collogh Cares says it is currently working with teams in Montreal, Toronto, as well as Sweden to create AI tools that will work with the ” coach of digital health” and will analyze its content.
“All the information collected by the patient will be accessible in real time by health professionals. They will be able to see if the patient is progressing quickly or not, says Collins Oghor. But above all, what we want is that we believe that AI will help us create recommendations. »
If, for example, each doctor has 500 patients with kidney problems and all the information collected by patients from several doctors allows us to find similarities or constants, this could help to find more solutions, to better understand the disease.
The Dr Collins Oghor, co-founder and CEO of Collogh Cares
Prior to commercialization, Collogh Cares products and technology will be tested in a handful of US states beginning in September 2023.
African Americans most affected
Why there rather than in Canada? “Because patients are better taken care of in Canada,” explains Dr.r Oghor. But also because, in the United States alone, $500 billion is spent annually on the treatment of kidney disease. Ultimately, it is also because kidney failure mainly affects the black population. African Americans make up only 14% of the population in the United States, but 35% of them receive dialysis treatments. »
Born in Nigeria, Collins Oghor, 30, arrived in Canada in 2009 to undertake university studies. After studying both medicine and an MBA at McGill, he left to travel the world, where he worked on public health projects, notably for the UN. Back in Montreal in 2020, he co-founded Collogh Cares with three other people, a Nigerian and two Torontonians.
His collaboration with Next AI intoxicates him to the highest degree. “Having access to people like Yoshua Bengi and sitting at the same table with them is incredible! The rest of the planet is watching and envying us. »
We want to say thanks to the writer of this article for this amazing content
Artificial intelligence | A tool to revolutionize medicine
Visit our social media profiles along with other pages related to themhttps://www.ai-magazine.com/related-pages/